In Brief: SpectraScience
This article was originally published in The Gray Sheet
Executive Summary
SpectraScience: Minneapolis-based company commences shipments of its Spectroscopic Guidewire systems to "key European medical centers." The system, according to the company, will be marketed for use in the "differentiation of atherosclerotic plaques and detection of intracoronary thrombus." Knowledge of the composition of thrombus can help cardiologists select "in a cost effective manner the appropriate angioplasty modality," SpectraScience says...